Forus Raises $150M at a $3B Valuation as Its AI Network Becomes How Medicine Reaches Patients
aiinsider ·
Healthcare technology company Forus has secured $150 million in Series C funding, achieving a post-money valuation of $3 billion. The round was led by Bain Capital Ventures, with all previous institutional backers also contributing to bring the firm's total capital raised above $300 million. Forus operates an AI-driven platform that assigns a dedicated digital agent to each prescription, automatically handling insurance verification, financial aid navigation, and pharmacy logistics to ensure patients receive their medications promptly. Currently utilized by medical professionals across all fifty states and reaching 85 percent of American residential areas, the system significantly reduces administrative delays that previously prevented many individuals from starting complex therapies. The newly acquired capital will enable the startup to broaden its clinical applications beyond its initial specialty, enhance its automated workflow capabilities, and scale its workforce. By streamlining the path from prescription to patient, the platform provides pharmaceutical manufacturers with valuable real-world adherence data while empowering clinicians to confidently prescribe cutting-edge treatments. Industry leaders note that this infrastructure is rapidly becoming the standard mechanism for distributing modern therapeutics throughout the United States healthcare system.
aiinsider